IWAI, T., MORIYA, Y., SHIRANE, M., FUJIMOTO-OUCHI, K., & MORI, K. (2011). Continuous inhibition of epidermal growth factor receptor phosphorylation by erlotinib enhances antitumor activity of chemotherapy in erlotinib-resistant tumor xenografts. D.A. Spandidos.
Citação norma ChicagoIWAI, TOSHIKI, YOICHIRO MORIYA, MASATOSHI SHIRANE, KAORI FUJIMOTO-OUCHI, and KAZUSHIGE MORI. Continuous Inhibition of Epidermal Growth Factor Receptor Phosphorylation By Erlotinib Enhances Antitumor Activity of Chemotherapy in Erlotinib-resistant Tumor Xenografts. D.A. Spandidos, 2011.
Citação norma MLAIWAI, TOSHIKI, et al. Continuous Inhibition of Epidermal Growth Factor Receptor Phosphorylation By Erlotinib Enhances Antitumor Activity of Chemotherapy in Erlotinib-resistant Tumor Xenografts. D.A. Spandidos, 2011.